Intravenous Immunoglobulin Market size is estimated to reach $17.1 billion by 2026, growing at a CAGR of 7.5% during the forecast period 2021-2026.

Platelet rich plasma (PRP), along with scaffold and stem cells, has been shown to be a significant source of autologous products in the field of regenerative medicine